论文部分内容阅读
在眼科领域中,单疱角膜炎(HSK)是一种发病率、复发率和致盲率都非常高的传染性眼病。近年来,由于皮质激素类药,及免疫抑制剂的广泛应用以及单纯疱疹病毒各毒株本身某些特性的转变,使得HSK的发病率、复发率与日俱增,病变层加深,视力损害加重。尽管有多种抗病毒药物,仍不能有效地预防潜伏和复发。一般说来抗病毒药物仅能抑制病毒复制和合成,而不能直接杀死已合成的病毒,不能阻止已合成的病毒的感染和扩散。所以,对HSK的治疗是比较困难的。人白细胞干扰素(IFN)在抗病毒感染中,可以保护正常人体细胞防止病毒
In the field of ophthalmology, herpes simplexis (HSK) is a contagious eye disease with a very high incidence of relapse and blinding. In recent years, due to the wide application of corticosteroids and immunosuppressive agents and the change of certain characteristics of the herpes simplex virus strains themselves, the incidence and recurrence rate of HSK are increasing day by day. The lesion layers are deepened and the visual impairment is aggravated. Despite a variety of antiviral drugs, can not effectively prevent the potential and recurrence. In general, antiviral drugs can only inhibit the virus replication and synthesis, but can not directly kill the virus has been synthesized, can not stop the virus has been synthesized and spread of the virus. Therefore, the treatment of HSK is more difficult. Human leukocyte interferon (IFN) protects normal human cells from viruses in antiviral infections